146 related articles for article (PubMed ID: 15601624)
1. TIM, a Dbl-related protein, regulates cell shape and cytoskeletal organization in a Rho-dependent manner.
Xie X; Chang SW; Tatsumoto T; Chan AM; Miki T
Cell Signal; 2005 Apr; 17(4):461-71. PubMed ID: 15601624
[TBL] [Abstract][Full Text] [Related]
2. Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells.
Olivo C; Vanni C; Mancini P; Silengo L; Torrisi MR; Tarone G; Defilippi P; Eva A
Oncogene; 2000 Mar; 19(11):1428-36. PubMed ID: 10723134
[TBL] [Abstract][Full Text] [Related]
3. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
[TBL] [Abstract][Full Text] [Related]
4. G Protein betagamma subunits stimulate p114RhoGEF, a guanine nucleotide exchange factor for RhoA and Rac1: regulation of cell shape and reactive oxygen species production.
Niu J; Profirovic J; Pan H; Vaiskunaite R; Voyno-Yasenetskaya T
Circ Res; 2003 Oct; 93(9):848-56. PubMed ID: 14512443
[TBL] [Abstract][Full Text] [Related]
5. FGF-2 induced reorganization and disruption of actin cytoskeleton through PI 3-kinase, Rho, and Cdc42 in corneal endothelial cells.
Lee HT; Kay EP
Mol Vis; 2003 Dec; 9():624-34. PubMed ID: 14685150
[TBL] [Abstract][Full Text] [Related]
6. Induction of the myofibroblastic phenotype in human gingival fibroblasts by transforming growth factor-beta1: role of RhoA-ROCK and c-Jun N-terminal kinase signaling pathways.
Smith PC; Cáceres M; Martinez J
J Periodontal Res; 2006 Oct; 41(5):418-25. PubMed ID: 16953819
[TBL] [Abstract][Full Text] [Related]
7. TGFbeta1-induced aortic endothelial morphogenesis requires signaling by small GTPases Rac1 and RhoA.
Varon C; Basoni C; Reuzeau E; Moreau V; Kramer IJ; Génot E
Exp Cell Res; 2006 Nov; 312(18):3604-19. PubMed ID: 16978608
[TBL] [Abstract][Full Text] [Related]
8. Rho and ROCK signaling in VEGF-induced microvascular endothelial hyperpermeability.
Sun H; Breslin JW; Zhu J; Yuan SY; Wu MH
Microcirculation; 2006; 13(3):237-47. PubMed ID: 16627366
[TBL] [Abstract][Full Text] [Related]
9. Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway.
Shah V; Bharadwaj S; Kaibuchi K; Prasad GL
Oncogene; 2001 Apr; 20(17):2112-21. PubMed ID: 11360195
[TBL] [Abstract][Full Text] [Related]
10. TrkB-T1 regulates the RhoA signaling and actin cytoskeleton in glioma cells.
Ohira K; Homma KJ; Hirai H; Nakamura S; Hayashi M
Biochem Biophys Res Commun; 2006 Apr; 342(3):867-74. PubMed ID: 16500620
[TBL] [Abstract][Full Text] [Related]
11. Activation of the guanine nucleotide exchange factor Dbl following ACK1-dependent tyrosine phosphorylation.
Kato J; Kaziro Y; Satoh T
Biochem Biophys Res Commun; 2000 Feb; 268(1):141-7. PubMed ID: 10652228
[TBL] [Abstract][Full Text] [Related]
12. [Serum response factor participates in RhoA-induced endothelial cell F-actin rearrangements].
Han YL; Yu HB; Yan CH; Meng ZM; Zhang XL; Kang J; Li SH; Wang SW
Sheng Li Xue Bao; 2005 Jun; 57(3):295-302. PubMed ID: 15968423
[TBL] [Abstract][Full Text] [Related]
13. Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc42.
Lorenzi MV; Castagnino P; Chen Q; Hori Y; Miki T
Oncogene; 1999 Aug; 18(33):4742-55. PubMed ID: 10467422
[TBL] [Abstract][Full Text] [Related]
14. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
Palmby TR; Abe K; Karnoub AE; Der CJ
Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
[TBL] [Abstract][Full Text] [Related]
15. Differential involvement of the integrin-linked kinase (ILK) in RhoA-dependent rearrangement of F-actin fibers and induction of connective tissue growth factor (CTGF).
Graness A; Giehl K; Goppelt-Struebe M
Cell Signal; 2006 Apr; 18(4):433-40. PubMed ID: 15970428
[TBL] [Abstract][Full Text] [Related]
16. Actin cytoskeleton dynamics promotes leptin-induced vascular smooth muscle hypertrophy via RhoA/ROCK- and phosphatidylinositol 3-kinase/protein kinase B-dependent pathways.
Zeidan A; Paylor B; Steinhoff KJ; Javadov S; Rajapurohitam V; Chakrabarti S; Karmazyn M
J Pharmacol Exp Ther; 2007 Sep; 322(3):1110-6. PubMed ID: 17562852
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
Ying Z; Jin L; Palmer T; Webb RC
Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
[TBL] [Abstract][Full Text] [Related]
18. A novel role for Lsc/p115 RhoGEF and LARG in regulating RhoA activity downstream of adhesion to fibronectin.
Dubash AD; Wennerberg K; García-Mata R; Menold MM; Arthur WT; Burridge K
J Cell Sci; 2007 Nov; 120(Pt 22):3989-98. PubMed ID: 17971419
[TBL] [Abstract][Full Text] [Related]
19. E1AF/PEA3 activates the Rho/Rho-associated kinase pathway to increase the malignancy potential of non-small-cell lung cancer cells.
Hakuma N; Kinoshita I; Shimizu Y; Yamazaki K; Yoshida K; Nishimura M; Dosaka-Akita H
Cancer Res; 2005 Dec; 65(23):10776-82. PubMed ID: 16322223
[TBL] [Abstract][Full Text] [Related]
20. RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation.
Sahai E; Alberts AS; Treisman R
EMBO J; 1998 Mar; 17(5):1350-61. PubMed ID: 9482732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
